Detailed answers about MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED, including incorporation, status, business activity, and accounts information.
When was MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED founded?
MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED was officially incorporated on 10 December 2002 and is registered under company number 04612905. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED?
MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED do?
MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED's registered address?
The registered office address of MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED is TRINITY HOUSE, THURSTON ROAD, NORTHALLERTON, NORTH YORKSHIRE, ENGLAND, DL6 2NA. This is the official address filed with Companies House for legal and statutory correspondence.
Is MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED financially stable?
The most recent accounts for MARK GIBSON MEDICOLEGAL CONSULTANCY LIMITED were made up to 31 December 2024, filed as MICRO ENTITY. Next accounts are due by 30 September 2026.